Work

Telavancin (vibativ), a new option for the treatment of gram-positive infections.

Year: 2011

Type: article

Abstract: Disclosure: The authors report no commercial or industrial relationships in regard to this article.

Source: PubMed Central

Authors: Polina Plotkin, Khusbu Patel, Amy Uminski, Nino Marzella

Language: English

Topic: Antimicrobial Resistance in Staphylococcus

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2190897100

FWCI: 1.535

Cites:

Cited by: 17

Related to: 10